Partnership aims to develop first-in-class, small molecule therapeutics directed at a novel non-incretin GPCR target for cardiometabolic diseases Deep Apple is eligible to receive up to $812 ...

Apple wants you to look good and retro for WWDC 2025 and has limited-edition hoodies, T-shirts and baby onesies with the company's original rainbow logo on it.

Orlando has brought back a version of its classic logo and showed off 3 new uniform looks for next season. Official release Franz Wagner, Jalen Suggs and Paolo Banchero model some of the Magic’s ...

The celebration of the new logo and uniforms will continue for the fans with the Magic hosting an event today, Tuesday, June 3 from 3:00 p.m. - 8:00 p.m. at Kia Center.

After 16 years with the same jersey and 14 years with the same logo, the Orlando Magic unveiled a massive rebrand by paying homage to their roots.. All the variations of the NEW @OrlandoMagic Logo ...

Basketball fans and sneakerheads are one step closer to the launch of Chicago Sky forward Angel Reese's signature line. On Wednesday, Reebok officially unveiled Reese's signature logo on social media.

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the first quarter of 2025.

BENGALURU: Biopharmaceutical startup Avammune Therapeutics has raised $12 million (Rs 100 crore) in a Series A funding round co-led by Capital 2B, Shastra VC, and Kotak Lifesciences Fund I, with ...

Google has just changed its “G” logo for the first time in nearly a decade. The new design blends the red, yellow, green, and blue into a gradient.

Some biotechnology companies, such as CRISPR Therapeutics (CRSP-0.32%), hope to use gene editing technology to treat, or even cure, diseases that existing drugs cannot.

Shape Therapeutics. By Rick Morgan – Inno Senior Reporter, Puget Sound Business Journal. May 6, 2025. Updated May 7, 2025 12:29pm PDT. Preview this article 1 min.

Novartis AG has agreed to buy U.S. biotech firm Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 billion. The Swiss company will pay $7 a share in cash up-front through a ...